Methotrexate and non-steroidal anti-inflammatory drugs in rheumatoid arthritis treatment;Association methotrexate et anti-inflammatoire non steroidien au cours de la polyarthrite rhumatoide

Therapie

Volumn 52, Issue 2, 1997, Pages 133-137

  Bertin, P ^a   Carpentier, N ^a   Vergne, P ^a   Bonnet, C ^a   Bannwarth, B ^b   Dehais, J ^b   Treves, R ^a  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

methotrexate; non steroidal anti inflammatory drug; rheumatoid arthritis

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; IBUPROFEN; INDOMETACIN; METHOTREXATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; SALICYLIC ACID DERIVATIVE; TENOXICAM; ANTIRHEUMATIC AGENT;

DRUG CLEARANCE; DRUG PROTEIN BINDING; HUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; DRUG COMBINATION; DRUG INTERACTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; METHOTREXATE;

EID: 0031089967     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Bannwarth B, Labat L, Moride Y, Schaeverbeke T. Methotrexate in rheumatoid arthritis. Drugs 1994; 47: 25-50.
2. Ellison NM, Servi RJ. Acute renal failure and death following sequential intermediate dose methotrexate and 5FU: a possible adverse effect due to concomitant indomethacin administration. Cancer Treat Rep 1985; 69: 342-343.
3. Stockley IH. Methotrexate NSAID interactions. Drug Intel Clin Pharm 1987; 21: 546.
4. Thyss A, Kubar J, Milano G, Namer M. Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen. Lancet 1986; i: 256-258.
5. Zuik M, Mandel M. Methotrexate-salicylate interaction: a clinical and experimental study. Surg Forum 1975; 26: 567-569.
6. Daly H, Boyle J, Roberts C, Scott G. Interaction between methotrexate and non-steroidal anti-inflammatory drugs. Lancet 1986; i; 557.
7. Gabrielli A, Leoni P, Danieli G. Methotrexate and non-steroidal anti-inflammatory drugs. BMJ 1987; 294: 776.
8. Singh R, Malaviya A, Pandey J, Guleria J. Fatal interaction between methotrexate and naproxen. Lancet 1986; i: 1390.
9. Herman RA, Veng-Petersen P, Hoffman J et al. Pharmacokinetics of low dose methotrexate in rheumatoid arthritis patients. J Pharm Sci 1989; 78: 165-171.
10. Kozloski GD, De Vito JM, Kisicki JC et al, The effect of food on the absorption of methotrexate sodium tablets in healthy volunteers. Arthritis Rheum 1992; 35: 761-764.
11. Stewart F, Pharm D, Fleming RA et al. Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis. Clin Pharmacol Ther 1990; 47: 540-546.
12. Bannwarth B, Pehourcq F, Schaeverbeke T et al. Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis. Clin Pharmacokinet 1996; 30: 194-210.
13. Claudepierre P, Urien S, Chevalier X et al. Methotrexate serum binding in rheumatoid arthritis. Clin Pharmacol 1994; 32: 113-115.
14. Anaya JM, Fahre D, Bressolle F et al. Effect of etodolac on methotrexate pharmacokinetics in patients with rheumatoid arthritis. J Rheumatol 1994: 21: 203-208.
15. Tracy S, Worster T, Bradley JD et al. Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis. Br J Pharm 1994; 37: 453-456.
16. Slordal L, Sager G, Jaeger R et al. Interactions with the protein binding of 7-hydroxy-methotrexate in human serum in vitro. Biochem Pharmacol 1988; 37: 607-611.
17. Slordal L, Sager G, Aarbakke J. Pharmacokinetic interactions with methotrexate: is 7-hydroxy-methotrexate the culprit? Lancet 1988; i: 591-592.
18. Combe B, Edno L, Lafforgue P et al. Interaction between methotrexate and non-steroidal anti-inflammatory drugs. Lancet 1986; i: 557.
19. Stewart F, Fleming RA, Germain BF et al. Aspirin alters methotrexate disposition in rheumatoid arthritis patients. Arthritis Rheum 1991; 34: 1514-1520.
20. Kremer M, Hamilton RA. The effect of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg. J Rheumatol 1995; 22: 2072-2077.